NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that it has signed up Takeda Rika Kogyo to distribute its genome analysis platform to life sciences research customers in Japan.
The exclusive agreement gives Takeda rights to sell the SmartChip System, which WaferGen is currently commercializing along with its SmartChip Gene Expression Profiling Services through an early-access program.
The SmartChip System includes a 5,184-assay SmartChip, the SmartChip Cycler, and the SmartChip Nanodispenser or Multi-Sample Nanodispenser for studying candidate genes and microRNA panels for disease research.
WaferGen's gene expression profiling services are provided to universities, research hospitals, and drug and biotech companies from the firm's Fremont, Calif. headquarters.
"By improving biomarker identification and validation, we believe that the SmartChip System will make a significant difference by enabling scientists to more quickly and effectively understand disease at the molecular level in order to target therapies," Takeda Rika Kogyo President Takuto Takeda said in a statement.